Press release
Artificial Blood Market Size to Reach USD 9,977.3 Million by 2035 as Demand for Emergency Blood Substitutes Expands
Artificial Blood Market Size
The artificial blood market share continues to attract attention as healthcare systems seek alternatives to conventional blood transfusions during shortages. Hemoglobin-based oxygen carriers remain in the leading product category, while research into perfluorocarbon emulsions, stem cell-derived products, and recombinant technologies continue to broaden commercial opportunities. The report highlights North America as the leading regional market, while Asia-Pacific is expected to record the fastest growth over the forecast period.
Get More About This Market Research Report and Industry Forecast: https://www.datamintelligence.com/research-report/artificial-blood-market
Recent Developments
• February 2026: Research activity increased across North America, Europe, and Asia-Pacific as healthcare organizations expanded the evaluation of artificial blood products for trauma care, emergency medicine, and surgical applications.
• January 2026: Progress in hemoglobin-based oxygen carriers and perfluorocarbon emulsions improved oxygen delivery performance and product stability, supporting ongoing clinical development.
• January 2026: Research institutions continued advancing stem cell-derived blood products and universal blood substitute programs aimed at addressing blood compatibility challenges.
• January 2026: Biotechnology companies increased efforts to improve manufacturing methods that support longer shelf life and reliable oxygen transport in artificial blood products.
Mergers and Acquisitions
• 2026: Biotechnology companies continued entering strategic research partnerships with academic institutions to accelerate artificial blood development and clinical evaluation.
• 2026: Collaboration agreements between healthcare organizations and product developers expanded research programs focused on emergency transfusion solutions.
• 2026: Companies strengthened licensing and co-development arrangements to support product validation, manufacturing capabilities, and commercialization planning.
• 2026: Research organizations broadened partnerships with government agencies to support artificial blood programs for emergency preparedness and defense healthcare applications.
Download a Free Sample PDF of the Market Research Report: https://www.datamintelligence.com/download-sample/artificial-blood-market?akash
Artificial Blood Market Segmentation
By Product Type
• Hemoglobin-based Oxygen Carriers
• Perfluorocarbon Emulsion
Hemoglobin-based oxygen carriers remain the leading product segment due to their ability to transport oxygen in emergency and critical care settings. Perfluorocarbon emulsions continue to gain attention for specialized oxygen delivery applications and ongoing clinical research.
By Source
• Human Hemoglobin
• Animal Hemoglobin
• Stem Cells
• Synthetic Polymers
• Microorganisms
• Others
Human and animal hemoglobin remain widely studied sources for artificial blood development, while stem cells and synthetic polymers are attracting growing research interest for creating safer and scalable blood substitutes.
By Process
• Synthetic Production
• Chemical Isolation
• Recombinant Biochemical Technology
Synthetic production continues to support large-scale manufacturing efforts, while recombinant biochemical technology is expanding as companies focus on improving product consistency, safety, and oxygen-carrying performance.
By Application
• Anemia
• Organ Transplantation
• Injuries and Trauma
• Cardiovascular Diseases
• Maternal Conditions
• Others
Trauma care and organ transplantation remain key application areas due to the need for rapid oxygen delivery when donor blood is unavailable. Demand is also increasing across cardiovascular care and other emergency medical settings.
By End User
• Hospitals
• Clinics
• Blood Banks
• Research Institutes
• Others
Hospitals account for the largest share owing to their extensive use in emergency care, surgery, and intensive care services. Research institutes continue advancing clinical studies, while blood banks and clinics support future adoption of artificial blood technologies.
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
North America leads the market with strong biotechnology research and advanced healthcare infrastructure, while Asia-Pacific is experiencing steady growth driven by expanding healthcare investment, research activities, and increasing demand for advanced transfusion solutions.
Key Players in the Artificial Blood Market
The artificial blood industry remains highly research-driven, with companies focusing on oxygen therapeutics, synthetic blood substitutes, and advanced biotechnology platforms. Most participants continue investing in clinical studies, product development, and partnerships that support future commercialization. The market share is expected to be influenced by successful regulatory progress, manufacturing capabilities, and clinical validation.
Top Key Players
• Hemarina
• KaloCyte Inc.
• SpheriTech Limited
• Hemoglobin Oxygen Therapeutics LLC
• Terumo Corporation
Hemarina
Hemarina develops marine-derived oxygen carrier technologies designed for medical applications requiring efficient oxygen transport. The company continues to advance research programs aimed at supporting emergency medicine, transplantation, and critical care.
KaloCyte Inc.
KaloCyte develops synthetic red blood cell technologies intended to improve oxygen delivery during trauma and acute blood loss. The company focuses on products that can complement existing transfusion practices while addressing blood availability challenges.
Get a Customized Market Research Report Tailored to Your Business Needs: https://www.datamintelligence.com/customize/artificial-blood-market?akash
Artificial Blood Market Regional Analysis
North America continues to lead the artificial blood market because of its well-established biotechnology sector, advanced healthcare infrastructure, and strong research funding. The region benefits from ongoing clinical studies, government-supported research programs, and active participation from biotechnology companies developing blood substitute technologies. Hospitals and research institutions continue evaluating artificial blood products for trauma care, emergency medicine, and organ transplantation.
Asia-Pacific is expected to record the fastest expansion during the forecast period. Growing healthcare investment, expanding hospital infrastructure, and increasing focus on biotechnology research are supporting regional demand. Countries across the region continue strengthening research capabilities while expanding access to advanced medical treatments. Europe also maintains steady development through continued research activities, supportive healthcare systems, and collaborations between biotechnology companies and academic institutions, contributing to favorable artificial blood market trends.
Conclusion
The artificial blood market forecast reflects growing interest in products that can support healthcare systems during blood shortages and emergency situations. Continued research into oxygen-carrying technologies, extended storage capabilities, and universal blood substitutes is expected to strengthen future commercial opportunities. Although regulatory approval and product safety remain important considerations, ongoing clinical progress continues to support market development.
The artificial blood market growth is also supported by increasing demand from trauma centers, emergency departments, military healthcare, and transplant programs. As research advances, manufacturers are expected to focus on improving product performance, scalability, and clinical acceptance while meeting regulatory requirements.
Unlock In-Depth Market Intelligence and Business Opportunities https://www.datamintelligence.com/buy-now-page?report=artificial-blood-market?akash
Industry Related Reports:
Multi-Cancer Early Detection Market
The global Multi-Cancer Early Detection Market reached USD 4.72 billion in 2025 and is projected to reach USD 32.75 billion by 2035, growing at a CAGR of 20.88% during 2026-2035. Rising demand for non-invasive cancer screening, liquid biopsy technologies, and early detection solutions is accelerating market growth.
Learn More About This Market: https://www.datamintelligence.com/research-report/multi-cancer-early-detection-market
CRISPR Gene Editing Market
The global CRISPR Gene Editing Market reached USD 5.23 billion by 2035 and is projected to grow at a CAGR of 11.9% during 2026-2035. Increasing investments in gene-editing research, biotechnology, and precision medicine are driving demand for CRISPR-based technologies.
Explore the Complete Market Outlook: https://www.datamintelligence.com/research-report/crispr-gene-editing-market
Explore In-Depth Japan Market Insights: https://www.datamintelligence.com/jp-market-research-report
Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Blood Market Size to Reach USD 9,977.3 Million by 2035 as Demand for Emergency Blood Substitutes Expands here
News-ID: 4605708 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Metabolic Disorders Therapeutics Market Size to Reach USD 171.20 Billion by 2033 …
According to DataM Intelligence, the metabolic disorders therapeutics market size was valued at USD 81.41 billion in 2025 and is projected to reach USD 171.20 billion by 2033, growing at a CAGR of 8.6% during the forecast period from 2026 to 2033. The market is expanding as the global burden of diabetes, obesity, hypercholesterolemia, and rare inherited metabolic diseases continues to increase.
Demand for effective treatment options has encouraged…
Hydrogen Compressor Market Size to Reach USD 3.20 Billion by 2033 as Green Hydro …
According to DataM Intelligence, the hydrogen compressor market was valued at USD 2.17 billion in 2025 and is projected to reach USD 3.20 billion by 2033, growing at a CAGR of 4.6% during the forecast period from 2026 to 2033. The market is expanding as hydrogen gains wider use across clean energy production, industrial processing, hydrogen refueling stations, and energy storage applications.
The growing focus on green hydrogen projects,…
Future of Pet Longevity and Anti-Aging Market 2033 | Pharmaceuticals and Geropro …
DataM Intelligence has published its latest research report, "Pet Longevity and Anti-Aging Market Size 2026." The report provides comprehensive analysis of market dynamics, including regional growth patterns, segment-wise performance, CAGR forecasts, competitive positioning, and revenue trends across key industry participants. It also examines the major factors driving market expansion, emerging opportunities in pet wellness and longevity solutions, and strategic developments shaping the industry.Designed to support informed business planning, the study…
Cryogenic Pump Market Growth 2033 | Centrifugal and Positive Displacement Pumps, …
DataM Intelligence has published its latest research report, "Cryogenic Pump Market Size 2026." The report provides a comprehensive analysis of market dynamics, including regional growth patterns, segment-wise performance, CAGR forecasts, competitive positioning, and revenue trends across key industry participants. It also examines the major factors driving market expansion, emerging business opportunities, technological advancements, and strategic developments shaping the cryogenic pump industry. Designed to support informed business planning and investment decisions,…
More Releases for Blood
Anthony Tony B Powell Releases I Am Drenched in the Blood of Jesus Christ Blood …
Image: https://www.aionewswire.com/storage/images/ckeditor//Author%20Photo_1761680899.jpg
A book that shows the true meaning of the blood of Jesus and how it changes lives
Blood sustains the body, but it is the blood of Jesus Christ that grants eternal life and salvation to the soul. In his new book, I Am Drenched in the Blood of Jesus Christ: Blood Bought, Blood Stained, Blood Washed [https://www.amazon.com/Am-Drenched-Blood-Jesus-Christ/dp/1662871961], Anthony B. Powell takes readers on a profound spiritual journey into the…
Global Blood Processing Consumables(CH 5) Market Size - By Product Type(blood ad …
Market Overview and Report Coverage
Blood Processing Consumables encompass various products and materials used in the collection, storage, processing, and transfusion of blood and blood components. This category includes items like blood bags, tubes, filters, and reagents essential for laboratories and hospitals in ensuring safe and effective blood management.
The current outlook for the Blood Processing Consumables market indicates robust growth driven by increasing healthcare needs, advancements in medical technology, and a…
Medical Blood Bag Market 2027 Global Analysis and Forecasts by Type (Single Bloo …
The medical blood bags are the instruments that are used to store, collect, transport, and transfuse blood and its components. The disposable blood bags replaced the use of glass bottles due to problems associated with the use of glass bottles including insufficient sterility, leading to contamination of the blood, and the development of air bubbles resulted in severe complications during blood transfusion.
Access Sample Report@: https://bit.ly/3rGMS4Q
Leading Players in the…
Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 …
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulation…
Blood Bank (Blood Banking) Market 2019 Analysis By American Red Cross, Japan Red …
According to this study, over the next five years the Blood Bank (Blood Banking) market will register a 7.7% CAGR in terms of revenue, the global market size will reach US$ 40500 million by 2024, from US$ 26000 million in 2019.
Blood Bank (Blood Banking) Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion,…
Blood Bank (Blood Banking) Market Stay on The top of this growing business Indus …
Reports Monitor released a new Global Blood Bank (Blood Banking) Market research study with over 100 industry informative desk and Figures spread through Pages and an in-depth TOC on “Blood Bank (Blood Banking) Market”.
Global Blood Bank (Blood Banking) market 2019 research lays out the knowledge to achieve positive growth and presents different methods for maximizing your profit. The market study puts forward estimates for Global Blood Bank (Blood Banking) Market 2019 analysis and Forecast…
